[
    [
        {
            "time": "2018-10-17",
            "original_text": "Pre-Market Earnings Report for October 17, 2018: ABT, USB, ASML, MTB, NTRS, MTG, UNF, UBSH, BMI, WGO",
            "features": {
                "keywords": [
                    "Earnings",
                    "Pre-Market",
                    "ABT",
                    "USB",
                    "ASML"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "finance",
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Pre-Market Earnings Report for October 17, 2018: ABT, USB, ASML, MTB, NTRS, MTG, UNF, UBSH, BMI, WGO",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 10,
                "Headline_Structure": 7,
                "Source_Recency": 3
            }
        },
        {
            "time": "2018-10-17",
            "original_text": "Abbott Laboratories Q3 Earnings Preview",
            "features": {
                "keywords": [
                    "Abbott",
                    "Laboratories",
                    "Q3",
                    "Earnings"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Abbott Laboratories Q3 Earnings Preview",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 4
            }
        },
        {
            "time": "2018-10-17",
            "original_text": "Can Abbott's (ABT) Steady Overall Growth Aid Q3 Earnings?",
            "features": {
                "keywords": [
                    "Abbott",
                    "Steady",
                    "Overall",
                    "Growth",
                    "Q3",
                    "Earnings"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Can Abbott's (ABT) Steady Overall Growth Aid Q3 Earnings?",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 4
            }
        },
        {
            "time": "2018-10-17",
            "original_text": "Barclays says to buy this name in medical tech",
            "features": {
                "keywords": [
                    "Barclays",
                    "buy",
                    "medical",
                    "tech"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "technology"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Barclays says to buy this name in medical tech",
                "Correlation": 6,
                "Sentiment": 8,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 5
            }
        },
        {
            "time": "2018-10-17",
            "original_text": "What to Expect from Medtronic’s Diabetes Segment",
            "features": {
                "keywords": [
                    "Medtronic",
                    "Diabetes",
                    "Segment"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "What to Expect from Medtronic’s Diabetes Segment",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "2018-10-17",
            "original_text": "[$$] The Strategies AbbVie Employed to Protect Humira From Copycats",
            "features": {
                "keywords": [
                    "AbbVie",
                    "Strategies",
                    "Protect",
                    "Humira",
                    "Copycats"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "[$$] The Strategies AbbVie Employed to Protect Humira From Copycats",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 9,
                "Entity_Density": 5,
                "Market_Scope": 6,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 5
            }
        }
    ]
]